MedTrace Logo

Reverse Colocated Integrated Care Intervention Among Persons With Severe Persistent Mental Illness at US-Mexico Border

NCT03881657 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 416

Last updated 2019-03-19

No results posted yet for this study

Summary

This study evaluated whether patients with severe and persistent mental illness (SPMI) who received coordinated co-located behavioral health and primary care services were more likely to improve health outcomes after 12 months compared to SPMI patients who receive only behavioral health services from the local mental health authority (LMHA) Tropical Texas Behavioral Health (TTBH).The study employed a randomized control trial (RCT) design where intervention participants receiving integrated behavioral health were compared to control participants receiving the usual care provided within an LMHA for SPMI patients. Patients were placed in each group using a randomized number process. Demographic and health outcome data were collected from intervention and control participants at baseline. Health outcome data was subsequently collected at 6-month and 12-month follow-up points.

Conditions

Interventions

BEHAVIORAL

Reverse Colocated Integrated Care

A reverse colocated integrated care model is one where primary care and preventive services are embedded within a behavioral health service setting.

BEHAVIORAL

Usual Care

Behavioral health services without primary care or integrated care services

Sponsors & Collaborators

  • Methodist Healthcare Ministries of South Texas, Inc.

    collaborator UNKNOWN

  • Social Innovation Fund

    collaborator UNKNOWN

  • Health Resources in Action, Inc.

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-11-24
Primary Completion
2017-08-22
Completion
2017-08-22

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03881657 on ClinicalTrials.gov